Novavax | NVAX - Capitalización De Mercado

Precio De Mercado
9.73
Cambio Diario
0.11 1.09%
Mensual
2.80%
Anual
26.46%
Q1 Expectativa
9.33




Capitalización De Mercado Cambio Fecha
Adma Biologics USD 3.52B 824M 2026-03
Agenus USD 1.66B 1.55B 2026-03
AstraZeneca USD 220.14B 68B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Cassava Sciences USD 83M 13M 2026-03
Geron USD 843M 31M 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 303.66B 40.58B 2026-03
Novavax USD 1.43B 340M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12